Personal information

Other IDs

ResearcherID: J-8127-2015

Keywords

Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Lymphocytic, Chronic; Myelodyslastic Syndrome

Countries

Italy

Activities

Collapse all

Employment (1)

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico: Milano, IT

(UOC Ematologia - Hematology Department)
Employment
Source: Self-asserted source
Gianluigi Reda

Education and qualifications (2)

Università degli Studi di Milano: Milano, Lombardia, IT

MD
Education
Source: Self-asserted source
Gianluigi Reda

Università degli Studi di Milano: Milano, Lombardia, IT

Education
Source: Self-asserted source
Gianluigi Reda

Works (35)

Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

American Journal of Hematology
2023-09 | Journal article
DOI: 10.1002/ajh.27009
Contributors: Andrea Visentin; Francesca Romana Mauro; Lydia Scarfò; Massimo Gentile; Lucia Farina; Gianluigi Reda; Isacco Ferrarini; Giulia Proietti; Enrico Derenzini; Francesca Cibien et al.
Source: check_circle
Crossref

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

American Journal of Hematology
2023-07 | Journal article
DOI: 10.1002/ajh.26927
Contributors: Fortunato Morabito; Giovanni Tripepi; Francesca Romana Mauro; Luca Laurenti; Gianluigi Reda; Riccardo Moia; Adalgisa Condoluci; Iolanda Vincelli; Annalisa Chiarenza; Ernesto Vigna et al.
Source: check_circle
Crossref

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

Blood Advances
2023-02-28 | Journal article
DOI: 10.1182/bloodadvances.2022007619
Contributors: Gianluigi Reda; Veronica Mattiello; Anna Maria Frustaci; Andrea Visentin; Francesca Romana Mauro; Idanna Innocenti; Massimo Gentile; Diana Giannarelli; Alessandro Noto; Ramona Cassin et al.
Source: check_circle
Crossref

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model

American Journal of Hematology
2022-05 | Journal article
DOI: 10.1002/ajh.26502
Contributors: Stefano Molica; Diana Giannarelli; Andrea Visentin; Gianluigi Reda; Paolo Sportoletti; Anna Maria Frustaci; Annalisa Chiarenza; Stefania Ciolli; Candida Vitale; Luca Laurenti et al.
Source: check_circle
Crossref

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study

American Journal of Hematology
2022-03 | Journal article
DOI: 10.1002/ajh.26437
Contributors: Andrea Visentin; Francesca Romana Mauro; Francesca Cibien; Candida Vitale; Gianluigi Reda; Alberto Fresa; Stefania Ciolli; Daniela Pietrasanta; Monia Marchetti; Roberta Murru et al.
Source: check_circle
Crossref

Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials

American Journal of Hematology
2021-08 | Journal article
DOI: 10.1002/ajh.26201
Contributors: Fortunato Morabito; Giovanni Tripepi; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Sabrina Bossio et al.
Source: check_circle
Crossref

TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases

American Journal of Hematology
2021-08 | Journal article
DOI: 10.1002/ajh.26235
Contributors: Fortunato Morabito; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Sabrina Bossio; Marzia Varettoni et al.
Source: check_circle
Crossref

Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

American Journal of Hematology
2021-05 | Journal article
DOI: 10.1002/ajh.26127
Contributors: Fortunato Morabito; Giovanni Tripepi; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Marzia Varettoni et al.
Source: check_circle
Crossref

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
2021-05-01 | Journal article
DOI: 10.1200/JCO.20.02619
Contributors: Guillermo Garcia-Manero; Valeria Santini; Antonio Almeida; Uwe Platzbecker; Anna Jonasova; Lewis R. Silverman; Jose Falantes; Gianluigi Reda; Francesco Buccisano; Pierre Fenaux et al.
Source: check_circle
Crossref

Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy

Leukemia
2020-09-04 | Journal article
DOI: 10.1038/s41375-020-0966-y
Contributors: Gianluigi Reda; Alessandro Noto; Ramona Cassin; Giulia Zamprogna; Chiara Borella; Lydia Scarfò; Lucia Farina; Alfredo Molteni; Paolo Ghia; Alessandra Tedeschi et al.
Source: check_circle
Crossref

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study

Journal of Hematology & Oncology
2018-12 | Journal article
DOI: 10.1186/s13045-018-0626-0
Contributors: Gianluigi Reda; Bruno Fattizzo; Ramona Cassin; Veronica Mattiello; Tatiana Tonella; Diana Giannarelli; Ferdinando Massari; Agostino Cortelezzi
Source: check_circle
Crossref

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

American Journal of Hematology
2018-09 | Journal article
DOI: 10.1002/ajh.25206
Contributors: Fortunato Morabito; Tait D Shanafelt; Massimo Gentile; Gianluigi Reda; Francesca Romana Mauro; Davide Rossi; Nicola Di Renzo; Stefano Molica; Francesco Angrilli; Annalisa Chiarenza et al.
Source: check_circle
Crossref

Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers

American Journal of Hematology
2017-07 | Journal article
DOI: 10.1002/ajh.24755
Contributors: Gianluigi Reda; Ramona Cassin; Bruno Fattizzo; Diana Giannarelli; Veronica Mattiello; Wilma Barcellini; Agostino Cortelezzi
Source: check_circle
Crossref

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma

American Journal of Hematology
2017-04 | Journal article
DOI: 10.1002/ajh.24714
Contributors: Francesca Romana Mauro; Piero Galieni; Alessandra Tedeschi; Luca Laurenti; Giovanni Del Poeta; Gianluigi Reda; Marina Motta; Alessandro Gozzetti; Roberta Murru; Maria Denise Caputo et al.
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

Biological and molecular characterization of a rare case of cutaneous Richter syndrome

Hematological Oncology
2016 | Journal article
DOI: 10.1002/hon.2327
Contributors: Gianluigi Reda; Ramona Cassin; Sonia Fabris; Gabriella Ciceri; Bruno Fattizzo; Mariarita Sciumè; Nicola Orofino; Umberto Gianelli; Antonino Neri; Agostino Cortelezzi
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report

Oncology Letters
2016 | Journal article
DOI: 10.3892/ol.2016.5549
Contributors: Gianluigi Reda; Bruno Fattizzo; Ramona Cassin; Elena Flospergher; Nicola Orofino; Umberto Gianelli; Wilma Barcellini; Agostino Cortelezzi
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

Leukemia Research
2015 | Journal article
DOI: 10.1016/j.leukres.2015.07.009
WOSUID:

WOS:000363427600010
Contributors: Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Vannata, Barbara; Efremov, Dimitar G.; Ciolli, Stefania; Del Poeta, Giovanni; Mauro, Francesca Romana; Cortelezzi, Agostino; Borza, Paola Anticoli et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience

American Journal of Hematology
2015 | Journal article
DOI: 10.1002/ajh.24127
WOSUID:

WOS:000363463600005
Contributors: Sciume, Mariarita; Vincenti, Daniele; Reda, Gianluigi; Orofino, Nicola; Cassin, Ramona; Giannarelli, Diana; Gaidano, Gianluca; Rossi, Davide; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial

Leukemia
2014 | Journal article
DOI: 10.1038/leu.2013.334
WOSUID:

WOS:000332845700016
Contributors: Cortelezzi, A.; Sciume, M.; Liberati, A. M.; Vincenti, D.; Cuneo, A.; Reda, G.; Laurenti, L.; Zaja, F.; Marasca, R.; Chiarenza, A. et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression

Leukemia & Lymphoma
2014 | Journal article
DOI: 10.3109/10428194.2013.856426
WOSUID:

WOS:000340224100013
Contributors: Barcellini, Wilma; Imperiali, Francesca G.; Zaninoni, Anna; Reda, Gianluigi; Consonni, Dario; Fattizzo, Bruno; Lonati, Silvia; Nobili, Lucia; Zanella, Alberto; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia

American Journal of Hematology
2013 | Journal article
DOI: 10.1002/ajh.23342
WOSUID:

WOS:000312536500006
Contributors: Maura, Francesco; Visco, Carlo; Falisi, Erika; Reda, Gianluigi; Fabris, Sonia; Agnelli, Luca; Tuana, Giacomo; Lionetti, Marta; Guercini, Nicola; Novella, Elisabetta et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

High Levels of Vascular Endothelial Growth Factor Protein Expression Are Associated With an Increased Risk of Transfusion Dependence in Myelodysplastic Syndromes

American Journal of Clinical Pathology
2013 | Journal article
DOI: 10.1309/ajcp503ybktggwnq
WOSUID:

WOS:000315608500015
Contributors: Gianelli, Umberto; Fracchiolla, Nicola S.; Bucciarelli, Paolo; Ferla, Valeria; Boiocchi, Leonardo; Savi, Federica; Moro, Alessia; Reda, Gianluigi; Bosari, Silvano; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

British Journal of Haematology
2012 | Journal article
DOI: 10.1111/j.1365-2141.2011.08965.x
WOSUID:

WOS:000299469200007
Contributors: Cortelezzi, Agostino; Gritti, Giuseppe; Laurenti, Luca; Cuneo, Antonio; Ciolli, Stefania; Di Renzo, Nicola; Musto, Pellegrino; Mauro, Francesca R.; Cascavilla, Nicola; Falchi, Lorenzo et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-cell Receptors

Clinical Cancer Research
2012 | Journal article
DOI: 10.1158/1078-0432.ccr-11-3019
WOSUID:

WOS:000302549900009
Contributors: Visco, Carlo; Maura, Francesco; Tuana, Giacomo; Agnelli, Luca; Lionetti, Marta; Fabris, Sonia; Novella, Elisabetta; Giaretta, Ilaria; Reda, Gianluigi; Barcellini, Wilma et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Lenalidomide in the treatment of chronic lymphocytic leukemia

Advances in hematology
2012 | Journal article
DOI: 10.1155/2012/393864
WOSUID:

MEDLINE:22851972
Contributors: Cortelezzi, Agostino; Sciume, Mariarita; Reda, Gianluigi
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia

Leukemia & Lymphoma
2012 | Journal article
DOI: 10.3109/10428194.2011.623258
WOSUID:

WOS:000300451100013
Contributors: Gritti, Giuseppe; Reda, Gianluigi; Maura, Francesco; Piciocchi, Alfonso; Baldini, Luca; Molica, Stefano; Neri, Antonino; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia

American Journal of Hematology
2012 | Journal article
DOI: 10.1002/ajh.23268
WOSUID:

WOS:000307843300022
Contributors: Reda, Gianluigi; Maura, Francesco; Gritti, Giuseppe; Gregorini, Anna; Binda, Francesca; Guidotti, Francesca; Piciocchi, Alfonso; Visco, Carlo; Rodeghiero, Francesco; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Quality of life and physicians' perception in myelodysplastic syndromes

American journal of blood research
2012 | Journal article
WOSUID:

MEDLINE:22762033
Contributors: Oliva, Esther Natalie; Finelli, Carlo; Santini, Valeria; Poloni, Antonella; Liso, Vincenzo; Cilloni, Daniela; Impera, Stefana; Terenzi, Adelmo; Levis, Alessandro; Cortelezzi, Agostino et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients

Immunopharmacology and Immunotoxicology
2012 | Journal article
DOI: 10.3109/08923973.2011.644295
WOSUID:

WOS:000306231900025
Contributors: Castelli, Roberto; Gritti, Giuseppe; Cannavo, Antonino; Moreo, Guido; Conti, Giancarlo; Reda, Gianluigi; Cortelezzi, Agostino
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

Plos One
2011 | Journal article
DOI: 10.1371/journal.pone.0023109
WOSUID:

WOS:000294128100007
Contributors: Santini, Valeria; Girelli, Domenico; Sanna, Alessandro; Martinelli, Nicola; Duca, Lorena; Campostrini, Natascia; Cortelezzi, Agostino; Corbella, Michela; Bosi, Alberto; Reda, Gianluigi et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

2.4 Expression of TLRs in B-CLL: Relationship with Disease Activity

Clinical Lymphoma Myeloma and Leukemia
2011-10 | Journal article
DOI: 10.1016/j.clml.2011.09.037
Contributors: Wilma Barcellini; Francesca G. Imperiali; Anna Zaninoni; Gianluigi Reda; Bruno Fattizzo; Agostino Cortelezzi
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

3.20 Stereotyped B-Cell Receptor is Associated with Immune Thrombocytopenia in CLL

Clinical Lymphoma Myeloma and Leukemia
2011-10 | Journal article
DOI: 10.1016/j.clml.2011.09.109
Contributors: Francesco Maura; Visco Carlo; Elisabetta Novella; Ilaria Giaretta; Giacomo Tuana; Luca Agnelli; Marta Lionetti; Sonia Fabris; Francesca Guidotti; Gianluigi Reda et al.
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

5.10 Combination of Bendamustine and Ofatumumab (Bendofa) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Preliminary Report

Clinical Lymphoma Myeloma and Leukemia
2011-10 | Journal article
DOI: 10.1016/j.clml.2011.09.164
Contributors: Agostino Cortelezzi; Anna Marina Liberati; Giuseppe Gritti; Antonio Cuneo; Gianluigi Reda; Luca Laurenti; Fortunato Morabito; Francesca R. Mauro; Alfonso Piciocchi; Marco Vignetti et al.
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search

Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study

Leukemia
2009 | Journal article
DOI: 10.1038/leu.2009.148
WOSUID:

WOS:000271666000010
Contributors: Cortelezzi, A.; Pasquini, M. C.; Gardellini, A.; Gianelli, U.; Bossi, A.; Reda, G.; Sarina, B.; Musto, P.; Barcellini, W.; Neri, A. et al.
Source: Self-asserted source
Gianluigi Reda via ResearcherID

Conjunctival hemorrhagic events associated with imatinib mesylate

International Journal of Hematology
2007 | Journal article
DOI: 10.1007/bf02983993
Contributors: Radaelli Franca; Vener Claudia; Ripamonti Francesco; Iurlo Alessandra; Colombi Mariangela; Artoni Andrea; Reda Gianluigi; Lambertenghi Deliliers Giorgio
Source: Self-asserted source
Gianluigi Reda via Crossref Metadata Search
How many people are using ORCID?